Skip to content

CRYO-CELL INTERNATIONAL, INC.: 10-Q filed 2024-04-15

What CRYO-CELL INTERNATIONAL, INC. reported in its quarterly report filed 2024-04-15 (fiscal Q1 2024): 50 published measures, 104 facts as tagged in accession 0000950170-24-044493.

This filing

Form
10-Q (quarterly report)
Filed
2024-04-15
Fiscal period
fiscal Q1 2024
Accession
0000950170-24-044493 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CRYO-CELL INTERNATIONAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-02-2961,710,774USD
At 2023-11-3061,220,770USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-02-2972,048,786USD
At 2023-11-3072,252,002USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-02-29-10,338,012USD
At 2023-11-30-11,031,232USD
At 2023-02-28-687,517USD
At 2022-11-30-1,524,302USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-02-29247,112USD
At 2023-11-30406,067USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-12-01 to 2024-02-29556,241USD91
2022-12-01 to 2023-02-28766,812USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-12-01 to 2024-02-29-356,865USD91
2022-12-01 to 2023-02-281,643,926USD90

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2023-12-01 to 2024-02-29457,722USD91
2022-12-01 to 2023-02-28375,600USD90

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-12-01 to 2024-02-29538,959USD91
2022-12-01 to 2023-02-28-772,847USD90

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-12-01 to 2024-02-29-341,049USD91
2022-12-01 to 2023-02-28-1,201,938USD90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-02-29-30,602,941USD
At 2023-11-30-31,159,182USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-12-01 to 2024-02-298,277,844shares91
2022-12-01 to 2023-02-288,467,074shares90

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-12-01 to 2024-02-298,325,027shares91
2022-12-01 to 2023-02-288,474,737shares90

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-12-01 to 2024-02-290.07USD/shares91
2022-12-01 to 2023-02-280.09USD/shares90

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-12-01 to 2024-02-290.07USD/shares91
2022-12-01 to 2023-02-280.09USD/shares90

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2023-12-01 to 2024-02-29238,269USD91
2022-12-01 to 2023-02-28447,715USD90

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-02-2921,605,273USD
At 2023-11-3020,996,883USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-12-01 to 2024-02-29307,355USD91
2022-12-01 to 2023-02-28313,174USD90

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-12-01 to 2024-02-29821,223USD91
2022-12-01 to 2023-02-281,683,171USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-02-299,452,076USD
At 2023-11-309,452,837USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-12-01 to 2024-02-29256,459USD91
2022-12-01 to 2023-02-28466,231USD90

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-02-2919,370,376USD
At 2023-11-3020,864,001USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-02-292,996,658USD
At 2023-11-303,174,584USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2024-02-291,941,411USD
At 2023-11-301,941,411USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2024-02-29972,154USD
At 2023-11-30989,121USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2024-02-296,726,893USD
At 2023-11-306,576,240USD
At 2023-02-286,522,456USD
At 2022-11-306,043,941USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2023-12-01 to 2024-02-29170,376USD91
2022-12-01 to 2023-02-28243,201USD90

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2024-02-29755,160USD
At 2023-11-30768,877USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2023-12-01 to 2024-02-294,339,645USD91
2022-12-01 to 2023-02-283,878,903USD90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-12-01 to 2024-02-29502,889USD91
2022-12-01 to 2023-02-2878,834USD90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-02-298,254,977shares
At 2023-11-308,286,785shares

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2024-02-29958,022USD
At 2023-11-301,033,157USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2024-02-291,022,942USD
At 2023-11-301,077,624USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2024-02-298,560,361USD
At 2023-11-308,595,678USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2024-02-29972,154USD
At 2023-11-30989,121USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2024-02-2930,653,425USD
At 2023-11-3030,771,050USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2024-02-2952,678,410USD
At 2023-11-3051,388,001USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2024-02-293,916,898USD
At 2023-11-305,170,809USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2024-02-299,394,821USD
At 2023-11-309,704,553USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-12-01 to 2024-02-29794,510USD91
2022-12-01 to 2023-02-281,214,527USD90

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-12-01 to 2024-02-29556,241USD91
2022-12-01 to 2023-02-28766,812USD90

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2023-12-01 to 2024-02-2986,047USD91
2022-12-01 to 2023-02-28369,950USD90

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2023-12-01 to 2024-02-2917,000USD91
2022-12-01 to 2023-02-2824,000USD90

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2023-12-01 to 2024-02-2963USD91
2022-12-01 to 2023-02-281,268USD90

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-12-01 to 2024-02-29-26,713USD91
2022-12-01 to 2023-02-28-468,644USD90

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-12-01 to 2024-02-29443,829USD91
2022-12-01 to 2023-02-28441,336USD90

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2023-12-01 to 2024-02-2957,630USD91
2022-12-01 to 2023-02-2833,072USD90

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2023-12-01 to 2024-02-2989,354USD91
2022-12-01 to 2023-02-2888,395USD90

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-12-01 to 2024-02-29439,413USD91
2022-12-01 to 2023-02-28665,419USD90

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2023-12-01 to 2024-02-29-49,856USD91
2022-12-01 to 2023-02-28-230,459USD90

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-12-01 to 2024-02-29-931,007USD91
2022-12-01 to 2023-02-28221,749USD90

Inspect the source

Entity
CRYO-CELL INTERNATIONAL, INC. / CIK 0000862692
Captured
2026-09-20T04:59:44.726Z
SEC response SHA-256
db6274ac13e8b9460d5d6692afefc40788c565b8fd343e40b722f12a7b8f95ac

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000862692.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))